These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 15804348)
1. Two cases of "cannabis acute psychosis" following the administration of oral cannabis. Favrat B; Ménétrey A; Augsburger M; Rothuizen LE; Appenzeller M; Buclin T; Pin M; Mangin P; Giroud C BMC Psychiatry; 2005 Apr; 5():17. PubMed ID: 15804348 [TBL] [Abstract][Full Text] [Related]
2. Cannabinoid content of some English reefers. Fairbairn JW; Hindmarch I; Simic S; Tylden E Nature; 1974 May; 249(454):276-8. PubMed ID: 4833245 [No Abstract] [Full Text] [Related]
3. Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users. van Wel JH; Kuypers KP; Theunissen EL; Toennes SW; Spronk DB; Verkes RJ; Ramaekers JG Br J Pharmacol; 2013 Dec; 170(7):1410-20. PubMed ID: 24106872 [TBL] [Abstract][Full Text] [Related]
4. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration. Schlienz NJ; Lee DC; Stitzer ML; Vandrey R Drug Alcohol Depend; 2018 Jun; 187():254-260. PubMed ID: 29689485 [TBL] [Abstract][Full Text] [Related]
5. Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness. Koethe D; Gerth CW; Neatby MA; Haensel A; Thies M; Schneider U; Emrich HM; Klosterkötter J; Schultze-Lutter F; Leweke FM Schizophr Res; 2006 Dec; 88(1-3):142-50. PubMed ID: 17005373 [TBL] [Abstract][Full Text] [Related]
7. The effects of cannabinoids on serum cortisol and prolactin in humans. Ranganathan M; Braley G; Pittman B; Cooper T; Perry E; Krystal J; D'Souza DC Psychopharmacology (Berl); 2009 May; 203(4):737-44. PubMed ID: 19083209 [TBL] [Abstract][Full Text] [Related]
8. Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol. Levin FR; Mariani JJ; Brooks DJ; Xie S; Murray KA Drug Alcohol Depend; 2010 Jan; 106(1):65-8. PubMed ID: 19733018 [TBL] [Abstract][Full Text] [Related]
9. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. D'Souza DC; Perry E; MacDougall L; Ammerman Y; Cooper T; Wu YT; Braley G; Gueorguieva R; Krystal JH Neuropsychopharmacology; 2004 Aug; 29(8):1558-72. PubMed ID: 15173844 [TBL] [Abstract][Full Text] [Related]
10. Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans. D'Souza DC; Pittman B; Perry E; Simen A Psychopharmacology (Berl); 2009 Mar; 202(4):569-78. PubMed ID: 18807247 [TBL] [Abstract][Full Text] [Related]
11. The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial. Englund A; Atakan Z; Kralj A; Tunstall N; Murray R; Morrison P J Psychopharmacol; 2016 Feb; 30(2):140-51. PubMed ID: 26577065 [TBL] [Abstract][Full Text] [Related]
12. What is the mechanism whereby cannabis use increases risk of psychosis? Luzi S; Morrison PD; Powell J; di Forti M; Murray RM Neurotox Res; 2008 Oct; 14(2-3):105-12. PubMed ID: 19073418 [TBL] [Abstract][Full Text] [Related]
13. Fitness to drive and cannabis: validation of two blood THCCOOH thresholds to distinguish occasional users from heavy smokers. Fabritius M; Augsburger M; Chtioui H; Favrat B; Giroud C Forensic Sci Int; 2014 Sep; 242():1-8. PubMed ID: 24999608 [TBL] [Abstract][Full Text] [Related]
14. Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans. Ranganathan M; Carbuto M; Braley G; Elander J; Perry E; Pittman B; Radhakrishnan R; Sewell RA; D'Souza DC Int J Neuropsychopharmacol; 2012 Oct; 15(9):1251-64. PubMed ID: 22243563 [TBL] [Abstract][Full Text] [Related]
15. Cannabis-induced psychosis associated with high potency "wax dabs". Pierre JM; Gandal M; Son M Schizophr Res; 2016 Apr; 172(1-3):211-2. PubMed ID: 26876313 [TBL] [Abstract][Full Text] [Related]
16. Psychological adverse effects of cannabis smoking: a tentative classification. Nigrete JC Can Med Assoc J; 1973 Jan; 108(2):195-6 passim. PubMed ID: 4569453 [TBL] [Abstract][Full Text] [Related]
17. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint. Fabritius M; Chtioui H; Battistella G; Annoni JM; Dao K; Favrat B; Fornari E; Lauer E; Maeder P; Giroud C Anal Bioanal Chem; 2013 Dec; 405(30):9791-803. PubMed ID: 24202191 [TBL] [Abstract][Full Text] [Related]
18. Non-smoker exposure to secondhand cannabis smoke II: Effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects. Herrmann ES; Cone EJ; Mitchell JM; Bigelow GE; LoDico C; Flegel R; Vandrey R Drug Alcohol Depend; 2015 Jun; 151():194-202. PubMed ID: 25957157 [TBL] [Abstract][Full Text] [Related]
19. The cannabis and psychosis connection questioned: a comment on Fergusson et al. 2005. Mirken B; Earleywine M Addiction; 2005 May; 100(5):714-5; author reply 715-6. PubMed ID: 15847630 [No Abstract] [Full Text] [Related]